10-Year study tracks safety of new silicone breast implants
NCT ID NCT06013514
First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time
Summary
This study follows 60 women aged 18 to 65 who receive Nagor PERLE silicone breast implants for breast reconstruction, augmentation, or revision surgery. Researchers will monitor complications like capsular contracture (hardening) and implant rupture over 10 years. The goal is to gather long-term safety and performance data on these implants.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Nagor PERLE silicone breast implants
What this could lead to
If successful, this study could confirm that these implants are safe and effective for breast reconstruction, augmentation, or revision over the long term.
What could go wrong
This is an observational study, not a controlled trial, so it cannot prove cause and effect. Complications like capsular contracture or rupture may still occur, and results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST RECONSTRUCTION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
NHS Manchester
RECRUITINGManchester, M13 9WL, United Kingdom
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••